跳至主要内容
临床试验/ACTRN12618001615279
ACTRN12618001615279已完成未知

Clinician Intervention to Reduce Fear of Recurrence in Cancer Survivors (CIFeR Study)

Psycho-Oncology Cooperative Group0 个研究点目标入组 61 人开始时间: 2018年10月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
61

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Educational / counselling / training

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • 1)Women aged 18 years and above with histologically confirmed early stage (I-III inclusive) breast cancer who have undergone treatment with curative intent
  • 2)Completed surgery and adjuvant chemotherapy/radiotherapy (where appropriate) greater than or equal to 6 months from time of registration (but may be on adjuvant hormone therapy)
  • 3)Willing and able to complete study requirements including patient-rated outcome (PRO) surveys without assistance or translation
  • 4)Completed signed written informed consent

排除标准

  • 1)Current severe major depression (as defined by >15 on DASS-21) and anxiety (>21 on DASS-21)
  • 2)Current psychotic illness or other psychiatric/cognitive condition that would impair the ability to participate in the intervention (as judged by the treating clinician)
  • 3)Patients who are unable to understand written or spoken English
  • 4)Objective evidence of recurrence or metastatic cancer of any type, as determined by the treating oncologist.

研究者

发起方
Psycho-Oncology Cooperative Group

相似试验